The Current Ratio of Black Diamond Therapeutics Inc (BDTX) is
8.42.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
8.42
|
| 2024-12-31 |
4.92
|
| 2023-12-31 |
6.82
|
| 2022-12-31 |
8.35
|
| 2021-12-31 |
9.14
|
| 2020-12-31 |
22.51
|
| 2019-12-31 |
31.78
|
| 2018-12-31 |
19.88
|
| 2017-12-31 |
3.59
|
| Ticker |
Name |
Value |
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
ADAP
|
Adaptimmune Therapeutics PLC
|
2.92
|
|
ALBO
|
Albireo Pharma Inc
|
5.93
|
|
HARP
|
Harpoon Therapeutics Inc
|
1.04
|
|
ARDX
|
Ardelyx, Inc.
|
4.31
|
|
CMRX
|
Chimerix Inc
|
5.70
|
|
MRUS
|
Merus NV
|
6.54
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
ADVM
|
Adverum Biotechnologies Inc
|
5.73
|
|
BTAI
|
BioXcel Therapeutics Inc
|
0.83
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
11.34
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
5.58
|
|
KDNY
|
Chinook Therapeutics Inc
|
7.59
|
|
MTEM
|
Molecular Templates Inc
|
0.97
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
CLNN
|
Clene Inc
|
0.83
|
|
EVLO
|
Evelo Biosciences Inc
|
4.16
|
|
SGTX
|
Sigilon Therapeutics Inc
|
2.40
|
|
TSHA
|
Taysha Gene Therapies, Inc.
|
12.23
|
|
VXRT
|
Vaxart Inc
|
1.57
|
|
TCRR
|
TCR2 Therapeutics Inc
|
2.77
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
AFMD
|
Affimed NV
|
3.25
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
3.90
|
|
DYN
|
Dyne Therapeutics, Inc.
|
22.25
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
ORIC
|
ORIC Pharmaceuticals, Inc.
|
14.13
|
|
PRTA
|
Prothena Corporation PLC
|
7.72
|
|
AKUS
|
Akouos Inc
|
14.06
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
CRTX
|
Cortexyme Inc
|
7.85
|
|
EPZM
|
Epizyme Inc
|
4.56
|
|
GTHX
|
G1 Therapeutics Inc
|
3.87
|
|
INBX
|
Inhibrx Biosciences Inc
|
3.93
|